News & Publications for:

Alex Evers

Enhanced GABAergic actions resulting from the coapplication of the steroid 3α-hydroxy-5α-pregnane-11,20-dione (alfaxalone) with propofol or diazepam

Posted on August 6, 2018

Lily Q. Cao, Michael C. Montana, Allison L. Germann, Daniel J. Shin, Sampurna Chakrabarti, Steven Mennerick, Carla M. Yuede, David F. Wozniak, Alex S. Evers & Gustav Akk. Scientific Reports, Volume 8, Issue 1, 1 December 2018, Article number 10341 Read More

Posted in: Axon Injury & Repair, HPAN, Neurodegeneration, Publications Faculty: , ,

High constitutive activity accounts for the combination of enhanced direct activation and reduced potentiation in mutated GABAA receptors

Posted on April 18, 2018

Allison L. Germann, Daniel J. Shin, Christina R. Kuhrau, Alexander D. Johnson, Alex S. Evers and Gustav Akk. Molecular Pharmacology, Volume 93, Issue 5, May 2018, Pages 468-476 Read More

Posted in: Axon Injury & Repair, Publications Faculty:

Propofol discovery may aid development of new anesthetics

Posted on September 26, 2013

Read More

Posted in: News Faculty:

Preventing memory of surgery

Posted on February 14, 2012

Alex Evers and colleagues show that FDA-approved device does not lower risk of intraoperative awareness compared to less costly method. Read More

Posted in: News Faculty:

Device no better than cheaper alternatives for preventing intraoperative awareness

Posted on November 5, 2011

FDA-approved device does not lower risk that patients will recall surgery. Read More

Posted in: News Faculty: